SCHEMBL13620937

SCHEMBL13620937

O=C(Cl)c1ccc(OC(F)F)c2oc3ccc([N+](=O)[O-])cc3c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 2/20 0.46
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
MAPT P10636 6/20 0.42
RAB9A P51151 3/20 0.42
HTT P42858 3/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
XBP1 P17861 1/20 0.42
CCR6 P51684 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
GLA P06280 1/20 0.38
POLB P06746 2/20 0.38
KDM1A O60341 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1301737 0.90 MAOA (0.43) PDE4DPDE4APDE4BPDE4CMEN1
SCHEMBL8267950 0.86 KMT2A (0.43) PDE4DPDE4APDE4BPDE4CMEN1
SCHEMBL1750895 0.86 HTT (0.43) MEN1KMT2ARAB9AHTTLMNA
SCHEMBL14457761 0.83 PDE4D (0.57) PDE4DPDE4APDE4BPDE4CMEN1
SCHEMBL13620929 0.83 MAPT (0.40) PDE4DPDE4APDE4BPDE4CMEN1
SCHEMBL4032324 0.82 PDE4D (0.69) PDE4DPDE4APDE4BPDE4CMEN1
SCHEMBL4755347 0.82 PDE4D (0.69) PDE4DPDE4APDE4BPDE4CMEN1
SCHEMBL4350121 0.81 MEN1 (0.37) MEN1KMT2AMAPTRAB9AHTT
SCHEMBL1302395 0.81 PTPN1 (0.44) MEN1KMT2AMAPTRAB9AHTT
SCHEMBL2493654 0.80 CYP1A2 (0.36) MEN1KMT2AMAPTRAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090281146-A1 PROCESS FOR THE PREPARATION OF N-(3,5-DICHLOROPYRID-4-YL)-4-DIFLUOROMETHOXY-8-METHANESULFONAMIDO-DIBENZO[B,D]FURAN-1-CARBOXAMIDE GLENMARK PHARMACEUTICALS, S.A. (CH) 2009-11-12 US disclosed
US-7563900-B2 Process for the preparation N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methane sulfonamido-dibenzo[b,d]furan-1-carboxamide GLENMARK PHARMACEUTICALS S.A. (CH) 2009-07-21 US disclosed
US-7563900-B2 Process for the preparation N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methane sulfonamido-dibenzo[b,d]furan-1-carboxamide GLENMARK PHARMACEUTICALS S.A. (CH) 2009-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281146-A1 PROCESS FOR THE PREPARATION OF N-(3,5-DICHLOROPYRID-4-YL)-4-DIFLUOROMETHOXY-8-METHANESULFONAMIDO-DIBENZO[B,D]FURAN-1-CARBOXAMIDE DHODH, QDPR, DPYD PDE4D 278/4885PDE4A 1099/4885PDE4B 587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.